Fennec Pharmaceuticals Inc. (FENC) — DEF 14A Filings
All DEF 14A filings from Fennec Pharmaceuticals Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Fennec Pharma Files 2025 Proxy Statement
— Apr 25, 2025 Risk: medium
Fennec Pharmaceuticals Inc. filed its DEF 14A on April 25, 2025, for the fiscal year ending December 31, 2024. The filing details executive compensation and oth -
Fennec Pharmaceuticals Inc. Announces Annual Meeting of Shareholders on June 25, 2024
— May 13, 2024 Risk: low
FENNEC PHARMACEUTICALS INC. (FENC) filed a Proxy Statement (DEF 14A) with the SEC on May 13, 2024. Fennec Pharmaceuticals Inc. will hold its annual meeting of s
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX